Brii Biosciences

company

About

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

  • 101 - 250

Details

Last Funding Type
Series C
Last Funding Money Raised
$155M
Industries
Biotechnology,Health Care,Innovation Management,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$415M
Brii Biosciences has raised a total of $415M in funding over 2 rounds. Their latest funding was raised on Mar 23, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 23, 2021 Series C $155M 1 Invesco Detail
May 24, 2018 Series Unknown $260M 1 ARCH Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Brii Biosciences is funded by 2 investors. Invesco and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Yes Series C
ARCH Venture Partners Yes Series Unknown